Dedicated to Research Since 1993
  •  

    info@genesismarketinsights.com

Global Osteoarthritis Treatment Market by Product (Drugs, Hyaluronic acid Injection) by Anatomy (Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis) – Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Osteoarthritis Treatment Market was valued at USD XX Billion in the year 2017. Global Osteoarthritis Treatment Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023.

North America region holds the highest market share in 2017 and is considered as the fastest growing market in the forecasted period. At a country level, the U.S region holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years.

The Osteoarthritis Treatment market is segmented on the basis of type of products, by anatomy and region. By product, Hyaluronic acid Injection was the largest type segment of the Osteoarthritis Treatments market in 2017 and is expected to grow with XX% CAGR in coming years. By Anatomy, the market is segmented into Ankle Osteoarthritis, Hip Osteoarthritis, Knee Osteoarthritis, Shoulder Osteoarthritis and Others.

Drivers:

            Rising Geriatric Population

Restraints:

            High Cost Associated with Hyaluronic Acid Products

Opportunities:

            Rising Demand for Minimally Invasive Surgical Procedures

Challenges:

            High Side Effects and Lack of Safety of Products 

Bayer AG (Germany), Iroko Pharmaceuticals (U.S), Lifecore Biomedical, LLC (U.S), Merck Serono (Switzerland), Pfizer Consumer Healthcare (U.S), Sanofi SA (France), Smith & Nephew plc. (U.K), Zimmer Biomet (U.S), Novartis AG (Switzerland), and Abiogen Pharma Spa (Italy) are some of the key players in the Global Osteoarthritis Treatment Market.

Key Benefits for Stakeholders

Osteoarthritis treatment products manufacturers and retailers

Raw material suppliers

Healthcare institutions (hospitals, medical schools, and outpatient clinics)

Industry associations

Government & Regulatory agencies and organizations

By Product

Drugs

            Non-steroidal anti-inflammatory drugs (NSAIDs)

            Corticosteroids

            Hyaluronic acid Injection

                        Single Injections

                        Multiple Injections

Others

By Anatomy

Ankle Osteoarthritis

Hip Osteoarthritis

Knee Osteoarthritis

Shoulder Osteoarthritis

Others

By Region

North America

Europe

Asia-Pacific

RoW

Key Market Players

Bayer AG

Iroko Pharmaceuticals

Lifecore Biomedical, LLC

Merck Serono

Pfizer Consumer Healthcare

Sanofi SA

Smith & Nephew plc.

Zimmer Biomet

Novartis AG

Abiogen Pharma Spa

(Another brief information of 10 companies will be provided in the report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

             2.1.1.1. Key Data from Secondary Research

       2.1.2. Primary Research

             2.1.2.1. Key Data from Primary Research

             2.1.2.2. Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Osteoarthritis Treatment Market, By Product

6.1 Drugs

            6.1.1 Non-steroidal anti-inflammatory drugs (NSAIDs)

            6.1.2 Corticosteroids

            6.1.3 Hyaluronic acid Injection

                        6.1.3.1 Single Injections

                        6.1.3.2 Multiple Injections

            6.1.4 Others

7. Global Osteoarthritis Treatment Market, By Anatomy

7.1 Ankle Osteoarthritis

7.2 Hip Osteoarthritis

7.3 Knee Osteoarthritis

7.4 Shoulder Osteoarthritis

7.5 Others

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Bayer AG

9.2 Iroko Pharmaceuticals

9.3 Lifecore Biomedical, LLC

9.4 Merck Serono

9.5 Pfizer Consumer Healthcare

9.6 Sanofi SA

9.7 Smith & Nephew plc.

9.8 Zimmer Biomet

9.9 Novartis AG

9.10 Abiogen Pharma Spa

(Another brief information of 10 companies will be provided in the report.)

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

* The list of tables and figures will be provided in the sample report.

Summary

No Content Available.

PURCHASE OPTIONS

ASK FOR SPECIAL PRICING

Related Reports